Subsequent validations in independent cohorts of chronic HF have demonstrated, in the National Institutes of Health RELAX HF trial, that IGFBP7 is a biomarker of diastolic dysfunction and functional capacity14–17. Here, IGFBP7 is linked to hydrops fetalis.